Literature DB >> 9323937

Histopathologic features of neovascularization in sickle cell retinopathy.

D S McLeod1, C Merges, A Fukushima, M F Goldberg, G A Lutty.   

Abstract

PURPOSE: To examine the histopathologic and morphometric features of neovascular lesions in human proliferative sickle cell retinopathy.
METHODS: Postmortem ocular tissue was obtained from three subjects (aged 20, 28, and 40 years) with SS hemoglobinopathy and prepared for adenosine diphosphatase flat-embedding. Morphometric analysis was performed before serial sectioning.
RESULTS: Numerous active and autoinfarcted lesions were found that represented virtually all stages in the life cycle of preretinal neovascularization. These formations ranged from single small loops extending from arteries and veins along the retinal surface to the typical complex, elevated sea fan formations. Sea fans developed at hairpin loops and at arteriovenous crossings. There was an average of 5.6 connections between sea fans and retinal vessels; of these, 45% were arteriolar, 52.5% were venular, and 2.6% were at the capillary level. Six of eight sea fans were located at arteriovenous crossings. Autoinfarction appeared to occur initially within the sea fan capillaries. The average height of sea fans was 123 microns above the retinal surface.
CONCLUSIONS: Preretinal neovascularization in sickle cell retinopathy can arise from both the arterial and venous sides of the retinal vasculature and can assume a variety of morphologic configurations. Multiple feeding arterioles and draining venules are common, and autoinfarction appears to occur initially at the preretinal capillary level rather than at feeding arterioles. Arteriovenous crossings may be a preferential site for sea fan development.

Entities:  

Mesh:

Year:  1997        PMID: 9323937     DOI: 10.1016/s0002-9394(14)70862-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Retinal and optic nerve head pathology in Susac's syndrome.

Authors:  D Scott McLeod; Howard S Ying; Colin A McLeod; Rhonda Grebe; Martin Lubow; John O Susac; Gerard A Lutty
Journal:  Ophthalmology       Date:  2011-03       Impact factor: 12.079

2.  The initial fetal human retinal vasculature develops by vasculogenesis.

Authors:  D Scott McLeod; Takuya Hasegawa; Tarl Prow; Carol Merges; Gerard Lutty
Journal:  Dev Dyn       Date:  2006-12       Impact factor: 3.780

Review 3.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

4.  Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy.

Authors:  M Kunz Mathews; D S McLeod; C Merges; J Cao; G A Lutty
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

5.  Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid.

Authors:  Gerard A Lutty; D Scott McLeod
Journal:  Vision Res       Date:  2005-10-04       Impact factor: 1.886

6.  Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Hao Pan; Andrea Kabosova; Mathias Montenarh; Khalil Ahmed; John S Penn; Candy K Chan; David R Hinton; Maria B Grant; Alexander V Ljubimov
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy.

Authors:  Murilo Rodrigues; Fabiana Kashiwabuchi; Monika Deshpande; Kathleen Jee; Morton F Goldberg; Gerard Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-12-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.